OmniAb partners with ArrowMark and Viking for antibody discovery

OmniAb partners with ArrowMark and Viking for antibody discovery
@OmniAbTech: OmniAb partners with ArrowMark, Viking

OmniAb has entered into a Technology License and Services Agreement with a newly-formed incubated company of ArrowMark Partners and Viking Global Investors.

This strategic partnership is aimed at enhancing antibody discovery processes leveraging innovative technologies. OmniAb, known for cutting-edge solutions in the immunology space, seeks to expand its footprint through this collaboration, aligning with prominent investment firms. ArrowMark and Viking Global continue to diversify their portfolios by backing ventures at the forefront of biotech research. This move underscores a growing trend of investment in the biotechnology sector, fostering advancements in therapeutic development.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.